Berkowitz Noah 4

What Happened Noah Berkowitz, Chief Medical Officer of Arvinas, sold 5,685 shares on 2026-02-13 at $11.89 per share, generating $67,595 in proceeds. The filing shows this was a sale (disposition) and not a purchase — sales are often routine; this one was performed to satisfy tax withholding and is not a discretionary trade.

Key Details

• Transaction date and price: 2026-02-13 — 5,685 shares @ $11.89 = $67,595.
• Filing date: 2026-02-18 (Form 4 accession 0001628280-26-009300).
• Shares owned after transaction: Not specified in the provided filing.
• Notable footnote: F1 — the sale was made automatically by the issuer to cover tax withholding related to the vesting/settlement of 25% of RSUs granted Feb 13, 2025; the sale was not discretionary.
• Transaction type/code: S (Sale); footnote indicates tax-withholding disposition (commonly reported as F).

Context This was an automatic, issuer-conducted sale to cover tax withholding on vested RSUs — a common occurrence that typically reflects tax logistics rather than insider sentiment. Such withholding-sales (cashless/automatic dispositions) should be interpreted differently from voluntary open-market purchases, which are more indicative of bullish conviction.